These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1672562)

  • 1. Tumor promotion as a target for estrogen/antiestrogen effects in rat hepatocarcinogenesis.
    Dragan YP; Xu YD; Pitot HC
    Prev Med; 1991 Jan; 20(1):15-26. PubMed ID: 1672562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of tamoxifen as a promoter of hepatocarcinogenesis in female Fischer F344 rats.
    Dragan YP; Fahey S; Street K; Vaughan J; Jordan VC; Pitot HC
    Breast Cancer Res Treat; 1994; 31(1):11-25. PubMed ID: 7981451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The initiation-promotion-progression model of rat hepatocarcinogenesis.
    Dragan YP; Sargent L; Xu YD; Xu YH; Pitot HC
    Proc Soc Exp Biol Med; 1993 Jan; 202(1):16-24. PubMed ID: 8093813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative stereological studies of a 'selection' protocol of hepatocarcinogenesis following initiation in neonatal male and female rats.
    Dragan YP; Campbell HA; Xu XH; Pitot HC
    Carcinogenesis; 1997 Jan; 18(1):149-58. PubMed ID: 9054601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of tamoxifen and toremifene on liver and kidney tumor promotion in female rats.
    Dragan VP; Vaughan J; Jordan VC; Pitot HC
    Carcinogenesis; 1995 Nov; 16(11):2733-41. PubMed ID: 7586193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of tamoxifen and two of its non-isomerizable fixed-ring analogs on multistage rat hepatocarcinogenesis.
    Dragan YP; Fahey S; Nuwaysir E; Sattler C; Babcock K; Vaughan J; McCague R; Jordan VC; Pitot HC
    Carcinogenesis; 1996 Mar; 17(3):585-94. PubMed ID: 8631149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative stereological analysis of the effects of age and sex on multistage hepatocarcinogenesis in the rat by use of four cytochemical markers.
    Xu YH; Campbell HA; Sattler GL; Hendrich S; Maronpot R; Sato K; Pitot HC
    Cancer Res; 1990 Feb; 50(3):472-9. PubMed ID: 1967547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic estrogens and tamoxifen as promoters of hepatocarcinogenesis.
    Yager JD; Shi YE
    Prev Med; 1991 Jan; 20(1):27-37. PubMed ID: 1672563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative stereologic study of the effects of varying the time between initiation and promotion on four histochemical markers in rat liver during hepatocarcinogenesis.
    Xu YH; Maronpot R; Pitot HC
    Carcinogenesis; 1990 Feb; 11(2):267-72. PubMed ID: 1967985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The natural history of neoplasia. Newer insights into an old problem.
    Pitot HC
    Am J Pathol; 1977 Nov; 89(2):402-11. PubMed ID: 21565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Threshold dose dependence in phenobarbital promotion of rat hepatocarcinogenesis initiated by diethylnitrosamine.
    Maekawa A; Onodera H; Ogasawara H; Matsushima Y; Mitsumori K; Hayashi Y
    Carcinogenesis; 1992 Mar; 13(3):501-3. PubMed ID: 1347716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the promotion of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the female rat.
    Dragan YP; Xu XH; Goldsworthy TL; Campbell HA; Maronpot RR; Pitot HC
    Carcinogenesis; 1992 Aug; 13(8):1389-95. PubMed ID: 1354083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diethylnitrosamine exposure-responses for DNA ethylation, hepatocellular proliferation, and initiation of carcinogenesis in rat liver display non-linearities and thresholds.
    Williams GM; Iatropoulos MJ; Jeffrey AM; Luo FQ; Wang CX; Pittman B
    Arch Toxicol; 1999 Sep; 73(7):394-402. PubMed ID: 10550482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the expression of some genes for enzymes of glutathione metabolism in hepatotoxicity and hepatocarcinogenesis.
    Pitot HC; Goodspeed D; Dunn T; Hendrich S; Maronpot RR; Moran S
    Toxicol Appl Pharmacol; 1989 Jan; 97(1):23-34. PubMed ID: 2563599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the separate and combined administration of mestranol and phenobarbital on the development of altered hepatic foci expressing placental form of glutathione S-transferase in the rat.
    Dragan YP; Singh J; Pitot HC
    Carcinogenesis; 1996 Sep; 17(9):2043-52. PubMed ID: 8824533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soybean isoflavone extract suppresses early but not later promotion of hepatocarcinogenesis by phenobarbital in female rat liver.
    Lee KW; Wang HJ; Murphy PA; Hendrich S
    Nutr Cancer; 1995; 24(3):267-78. PubMed ID: 8610046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporation of bromodeoxyuridine in glutathione S-transferase-positive hepatocytes during rat multistage hepatocarcinogenesis.
    Dragan YP; Hully J; Crow R; Mass M; Pitot HC
    Carcinogenesis; 1994 Sep; 15(9):1939-47. PubMed ID: 7923588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver.
    Cattley RC; Popp JA
    Cancer Res; 1989 Jun; 49(12):3246-51. PubMed ID: 2566380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promotion potential of tamoxifen on hepatocarcinogenesis in female SD or F344 rats initiated with diethylnitrosamine.
    Kim DJ; Han BS; Ahn B; Lee KK; Kang JS; Tsuda H
    Cancer Lett; 1996 Jun; 104(1):13-9. PubMed ID: 8640739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of the dose of diethylnitrosamine on the initiation of altered hepatic foci in neonatal female rats.
    Dragan YP; Xu YH; Pitot HC
    Carcinogenesis; 1993 Mar; 14(3):385-91. PubMed ID: 8095861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.